Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of aripiprazole 10 mg tablets vs Abilify in healthy Thai volunteers under fasting conditions
TCTR20240524006Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aripiprazole (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Status: unknown.
02
Drugs
aripiprazole
Beyond the preview
Go deeper on TCTR20240524006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240524006.